Cancer News and Research

Latest Cancer News and Research

New UW-Madison study links two unrelated cancer treatments

A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.

14 Jul 2015

Duke University researchers devise new method for making potential nanoscale cancer treatment

In a move akin to adding chemical weapons to a firebomb, researchers at Duke University have devised a method for making a promising nanoscale cancer treatment even more deadly to tumors.

14 Jul 2015

Cedars-Sinai's groundbreaking online registry improves participation in clinical research

Research for Her, Cedars-Sinai's groundbreaking online registry that matches women with research studies and clinical trials, enrolled study participants more quickly when compared with traditional paper-based registries, according to new research published in the journal Gynecologic Oncology.

14 Jul 2015

Colorectal cancer patients diagnosed during screening colonoscopy survive longer

Patients whose colorectal cancer (CRC) is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy.

14 Jul 2015

Postmenopausal women with kidney, bladder stones not at increased risk for osteoporosis

Postmenopausal women with kidney or bladder stones are not at increased risk for osteoporosis, but they do have about a 15 percent increased risk of another painful stone, physician-scientists report.

14 Jul 2015

Researchers identify genetic abnormalities that lead to skin SCC

Squamous cell carcinoma (SCC) of the skin is one of the most frequent cancers in humans affecting more than half million new persons every year in the world. The transformation of a normal cell to a cancer cell is caused by an accumulation of genetic abnormalities in the progeny of single cells. The spectrum of genetic anomalies found in a variety of human cancers have been described.

14 Jul 2015

New understanding of keratin 17 protein could lead to development of better ways to prevent cancer

New research from the Johns Hopkins Bloomberg School of Public Health suggests that the protein keratin 17 - the presence of which is used in the lab to detect and stage various types of cancers - is not just a biomarker for the disease, but may play a critical role in tumor growth.

14 Jul 2015

Chromosomes play active role in animal cell division

Canadian and British researchers have discovered that chromosomes play an active role in animal cell division. This occurs at a precise stage - cytokinesis - when the cell splits into two new daughter cells.

14 Jul 2015

Study shows that Anisina has potential to improve effectiveness of chemotherapy in children with cancer

US-Australian drug discovery company, Novogen Limited, today announced details of an in vivo proof of concept study that demonstrates their lead anti-tropomyosin drug candidate, Anisina, has the potential to improve the effectiveness of chemotherapy in children and reduce life-long side-effects.

14 Jul 2015

QIAGEN's therascreen EGFR RGQ PCR Kit to guide use of IRESSA for in NSCLC treatment

QIAGEN N.V. today received U.S. marketing (PMA) approval of its therascreen EGFR RGQ PCR Kit (therascreen EGFR test) as a companion diagnostic to guide the use of AstraZeneca's IRESSA (gefitinib) in the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC).

From QIAGEN Manchester Limited 14 Jul 2015

University of Twente scientists take significant step in breast cancer research

Scientists at the research Institute MIRA at the University of Twente have been working for some time on a new technique to detect breast cancer. The technique based on the physical principle of photoacoustics, has been christened PAMmography. It uses short bursts of light that cause ultrasonic waves to be generated in places with high density of blood vessels, such as in the vicinity of malignant tumours.

13 Jul 2015

FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

Blueprint Medicines today announced that the U.S. Food and Drug Administration accepted the Company's Investigational New Drug (IND) applications to begin Phase 1 clinical trials for its two lead drug candidates: BLU-554 for the treatment of advanced hepatocellular carcinoma (HCC) and cholangiocarcinoma, and BLU-285 for unresectable, treatment-resistant gastrointestinal stromal tumor (GIST).

13 Jul 2015

Accuray, RaySearch sign long-term collaboration agreement for RayCare oncology information system

Accuray Incorporated and RaySearch Laboratories AB (publ) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.

13 Jul 2015

OncoGenex's custirsen Phase 3 ENSPIRIT trial for treatment of NSCLC patients continues as planned

OncoGenex Pharmaceuticals, Inc. announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee (IDMC). This decision was based upon completion of the second and final planned interim futility analysis.

13 Jul 2015

New surgical method preserves long-term renal function following removal of renal tumours

Renal cell carcinomas are one of the most common types of cancer. In order to preserve its wide range of functions, every effort is made not to remove the entire kidney, but rather just a portion of it. A surgical method that preserves long-term renal function has now been carried out successfully for the first time in the Department of Urology at the MedUni Vienna and Vienna General Hospital.

13 Jul 2015

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

13 Jul 2015

Study offers new way to suppress growth factors related to cancer cell proliferation

Cancer cells need life-essential molecules to proliferate. These so-called growth factors are activated by ectodomain shedding of precursor proteins on the outside of the plasma membrane, mainly carried out by three human cleavage enzymes. A pharmaceutical blocking of these enzymes could hinder cancer from growing but would also inhibit other life-essential processes.

13 Jul 2015

Three European medical centers planning upgrades to Elekta's stereotactic radiosurgery system for the brain

Three foremost medical centers in the United Kingdom and Germany have ordered and are now planning upgrades to Elekta's latest generation stereotactic radiosurgery system for the brain, Leksell Gamma Knife Icon, to provide the most advanced brain radiosurgery treatments for their patients.

From Elekta 13 Jul 2015

Cancer survivors' options for adoption may be limited by policies set by adoption agencies

A new study has found that cancer survivors' options for adoption may be limited by adoption agencies' policies. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also indicates that a training program for oncology healthcare providers can help them provide valuable information to patients who are making decisions about fertility and adoption.

13 Jul 2015

KF-SYSCC creates paperless, filmless clinical process in radiation oncology to enhance patient safety

The Koo Foundation Sun Yat-Sen Cancer Center has established an entirely paperless and filmless clinical process in radiation oncology, designed to enhance patient safety as well as operational efficiency. Using the ARIA oncology information system from Varian Medical Systems, the clinical team has automated essential tasks, built in safety-checks, and centralized patient information for easier access by staff members.

13 Jul 2015

Cancer News and Research

Latest Cancer News and Research

New UW-Madison study links two unrelated cancer treatments

Duke University researchers devise new method for making potential nanoscale cancer treatment

Cedars-Sinai's groundbreaking online registry improves participation in clinical research

Colorectal cancer patients diagnosed during screening colonoscopy survive longer

Postmenopausal women with kidney, bladder stones not at increased risk for osteoporosis

Researchers identify genetic abnormalities that lead to skin SCC

New understanding of keratin 17 protein could lead to development of better ways to prevent cancer

Chromosomes play active role in animal cell division

Study shows that Anisina has potential to improve effectiveness of chemotherapy in children with cancer

QIAGEN's therascreen EGFR RGQ PCR Kit to guide use of IRESSA for in NSCLC treatment

University of Twente scientists take significant step in breast cancer research

FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

Accuray, RaySearch sign long-term collaboration agreement for RayCare oncology information system

OncoGenex's custirsen Phase 3 ENSPIRIT trial for treatment of NSCLC patients continues as planned

New surgical method preserves long-term renal function following removal of renal tumours

Too much transparency in clinical trials data may inhibit drug development, says researchers

Study offers new way to suppress growth factors related to cancer cell proliferation

Three European medical centers planning upgrades to Elekta's stereotactic radiosurgery system for the brain

Cancer survivors' options for adoption may be limited by policies set by adoption agencies

KF-SYSCC creates paperless, filmless clinical process in radiation oncology to enhance patient safety

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in